NOTTINGHAM, England, Dec. 4, 2025 /PRNewswire/ -- Quotient Sciences, a leading global drug development, research and manufacturing accelerator, and Intrepid Labs, the AI leader in pharmaceutical ...
Quotient Sciences, the drug development and manufacturing accelerator, announced that it has acquired Arcinova, the U.K.-based multiservice contract development and manufacturing organization (CDMO).
The MarketWatch News Department was not involved in the creation of this content. CAMBRIDGE, Mass., and CAMBRIDGE, United Kingdom, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Quotient Therapeutics, a company ...
BOSTON, Dec. 11, 2025 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, and Quotient Sciences, a leading global clinical ...
NOTTINGHAM, England, Feb. 8, 2023 /PRNewswire/ -- Quotient Sciences, the drug development and manufacturing accelerator, today announced that it has completed an expansion of its early-phase ...
NOTTINGHAM, England, Aug. 31, 2022 /PRNewswire/ -- Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ: ENSC) (OTC PINK: ENSCW), a clinical-stage biotech company applying transformative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback